Literature DB >> 30206384

Gene therapy for neurological disorders: progress and prospects.

Benjamin E Deverman, Bernard M Ravina, Krystof S Bankiewicz, Steven M Paul, Dinah W Y Sah.   

Abstract

This corrects the article DOI: 10.1038/nrd.2018.110.

Entities:  

Year:  2018        PMID: 30206384     DOI: 10.1038/nrd.2018.158

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  1 in total

Review 1.  Gene therapy for neurological disorders: progress and prospects.

Authors:  Benjamin E Deverman; Bernard M Ravina; Krystof S Bankiewicz; Steven M Paul; Dinah W Y Sah
Journal:  Nat Rev Drug Discov       Date:  2018-08-10       Impact factor: 84.694

  1 in total
  23 in total

1.  Modulation of Sialic Acid Dependence Influences the Central Nervous System Transduction Profile of Adeno-associated Viruses.

Authors:  Blake H Albright; Katherine E Simon; Minakshi Pillai; Garth W Devlin; Aravind Asokan
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

Review 2.  Strategies for delivering therapeutics across the blood-brain barrier.

Authors:  Georg C Terstappen; Axel H Meyer; Robert D Bell; Wandong Zhang
Journal:  Nat Rev Drug Discov       Date:  2021-03-01       Impact factor: 84.694

Review 3.  Live-Animal Epigenome Editing: Convergence of Novel Techniques.

Authors:  J Antonio Gomez; Ulrika Beitnere; David J Segal
Journal:  Trends Genet       Date:  2019-05-22       Impact factor: 11.639

Review 4.  Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier?

Authors:  Richard J Price; Delaney G Fisher; Jung Soo Suk; Justin Hanes; Han Seok Ko; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2019-03-25       Impact factor: 10.338

5.  Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain.

Authors:  Xintao Zhang; Zheng Chai; Amanda Lee Dobbins; Michelle S Itano; Charles Askew; Zhe Miao; Hongqian Niu; R Jude Samulski; Chengwen Li
Journal:  Biomaterials       Date:  2021-12-31       Impact factor: 12.479

Review 6.  Considerations When Developing Blood-Brain Barrier Crossing Drug Delivery Technology.

Authors:  Robert D Bell
Journal:  Handb Exp Pharmacol       Date:  2022

7.  Transduction of Systemically Administered Adeno-Associated Virus in the Colonic Enteric Nervous System and c-Kit Cells of Adult Mice.

Authors:  Lixin Wang; Pu-Qing Yuan; Collin Challis; Sripriya Ravindra Kumar; Yvette Taché
Journal:  Front Neuroanat       Date:  2022-06-06       Impact factor: 3.543

8.  Systemic administration of AAV-Slc25a46 mitigates mitochondrial neuropathy in Slc25a46-/- mice.

Authors:  Li Yang; Jesse Slone; Zhuo Li; Xiaoting Lou; Yueh-Chiang Hu; Luis F Queme; Michael P Jankowski; Taosheng Huang
Journal:  Hum Mol Genet       Date:  2020-03-13       Impact factor: 6.150

Review 9.  miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases.

Authors:  Jinying Xu; Yangyang Zheng; Yulin Li; Guangfan Chi; Liangjia Wang; Yining Liu; Xishu Wang
Journal:  Cell Mol Neurobiol       Date:  2021-04-22       Impact factor: 4.231

Review 10.  Engineering adeno-associated virus vectors for gene therapy.

Authors:  Chengwen Li; R Jude Samulski
Journal:  Nat Rev Genet       Date:  2020-02-10       Impact factor: 59.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.